Publications by authors named "Chee K Lee"

Claim this Profile
S
Survival with Osimertinib plus Chemotherapy in -Mutated Advanced NSCLC.
Pasi A Jänne, David Planchard, Kunihiko Kobayashi, James Chih-Hsin Yang, Ying Liu, Chee Khoon Lee

N Engl J Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of TP53 classifications in previously treated advanced driver-negative non-small cell lung cancer: A biomarker analysis of the OAK and POPLAR randomized clinical trials.
Deborah Di-Xin Zhou, Sarah J Lord, Frank Po-Yen Lin, Wendy A Cooper, Milita Zaheed, Chee Khoon Lee

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.
Chee Khoon Lee, Apriliana E R Kartikasari, Nirashaa T Bound, Katherine E Francis, Kristy Shield-Artin, Yeh Chen Lee

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microemulsion-based formulation of enterocin CC2: a novel antimicrobial solution targeting Streptococcus mutans.
Zhang Jin Ng, Choon Fu Goh, Ana Masara Ahmad Mokhtar, Rozi Nuraika Binti Ramli, Chee Keong Lee

Drug Deliv Transl Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinion.
Gee-Chen Chang, Akhil Kapoor, Chee Khoon Lee, Chunxia Su, Daniel Chan

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating advanced lung cancer care, patient-physician alliance, cancer stigma, and psychosocial support in Asia-Pacific: perspectives from patients, caregivers, and physicians.
Chee Khoon Lee, Xue Yang, Yasushi Goto, Kang Yun Lee, Hyung Seok Yim

Future Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Under the radar-frequency, timing, duration, and trajectory of lower-grade adverse events in clinical trials of anti-cancer therapies.
Katherine E Francis, Sarah J Lord, Sandy Simon, Michael Friedlander, Val Gebski, Chee Khoon Lee

Oncologist· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential and Sustainable Bioprocessing of Enterocin CC2: A Probiotic-Derived Antimicrobial Targeting Streptococcus mutans in Oral Health.
Zhang Jin Ng, Chee-Yuen Gan, Mazni Abu Zarin, Chee Keong Lee, John Chi-Wei Lan

Probiotics Antimicrob Proteins· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of results from the FLAURA2 study: Initial (first-line) osimertinib treatment with or without chemotherapy in patients with untreated EGFR-mutated advanced NSCLC.
David Planchard, Pasi A Jänne, Ying Cheng, James Chih-Hsin Yang, Noriko Yanagitani, Chee Khoon Lee

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of results from the FLAURA2 study: Effects of initial (first-line) osimertinib plus chemotherapy on the brain in patients with EGFR-mutated advanced non-small cell lung cancer.
Pasi A Jänne, David Planchard, Kunihiko Kobayashi, Ying Cheng, Chee Khoon Lee

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Somatic Genomic Variants of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced Non-Small Cell Lung Cancer.
Deborah Di-Xin Zhou, Janene Dalrymple, Danielle Klingberg, Frank Po-Yen Lin, Sarah J Lord, Chee Khoon Lee

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations.
Adel Shahnam, Alexander Davis, Lauren Julia Brown, Isaac Sullivan, Kevin Lin, Chee Khoon Lee

Lung Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab, Tremelimumab, and Platinum Chemotherapy in Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE).
Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, Chao-Hua Chiu, Antony J Mersiades

JTO Clin Res Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
Katherine Elizabeth Francis, Sandy Simon, Val Gebski, Florence Joly, Jonathan A Ledermann, Chee Khoon Lee

Gynecol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations.
Mengzhao Wang, Yan Xu, Wen-Tsung Huang, Wu-Chou Su, Bo Gao, Chee Khoon Lee

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysis.
Angelina Tjokrowidjaja, Peey-Sei Kok, Yoland C Antill, Clare L Scott, Linda R Mileshkin, Chee K Lee

JNCI Cancer Spectr· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona Meeting.
Jalid Sehouli, Jolijn Boer, Alison H Brand, Amit M Oza, Jennifer O'Donnell, Chee Khoon Lee

Int J Gynecol Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for assessing evidence for biomarker-targeted therapies in rare cancers-an extrapolation framework.
Doah Cho, Sarah J Lord, Robyn Ward, Maarten IJzerman, Andrew Mitchell, Chee Khoon Lee

Ther Adv Med Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation.
Subotheni Thavaneswaran, Frank Lin, John P Grady, David Espinoza, Min Li Huang, Chee Khoon Lee

NPJ Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET Collaboration.
Kristy P Robledo, Shilo Lefresne, Yu Yang Soon, Arjun Sahgal, Mark B Pinkham, Chee Khoon Lee

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipase-catalyzed solvent-free synthesis of monoglycerides from biodiesel-derived crude glycerol: Optimized using response surface methodology.
Hong Wang, HongPeng Li, Chee Keong Lee, Noreen Suliani Mat Nanyan, Guan Seng Tay

Heliyon· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor.
Angelina Tjokrowidjaja, M L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor R Mirza, Chee K Lee

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review on utilization of biodiesel-derived crude glycerol in sustainable polymers preparation.
Hong Wang, Hongpeng Li, Chee Keong Lee, Noreen Suliani Mat Nanyan, Guan Seng Tay

Int J Biol Macromol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Yu Yang Soon, Teng Hwee Tan, Chee Khoon Lee, Martin Stockler

BMJ Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis